Speed up your rule in/out of AMI using PATHFAST. PATHFAST combines lab accuracy with POC flexibility to enable you to deliver patient results faster at the point of care. High precision and conformity with ESC and IFCC guidelines makes PATHFAST the ideal tool for providing differential diagnosis with parallel processing of 6 samples in only a few minutes on whole blood, serum or plasma. PATHFAST hs-cTnI can be used as an aid in the diagnosis of acute myocardial infarction and in the risk stratification of patients presenting with acute coronary syndromes. In addition to the diagnosis of AMI, detection of low cardiac troponin levels may make it possible to predict information in terms of short- and long-term mortality of patients.
PATHFAST Presepsin is used as an aid in the diagnosis and prognosis of sepsis, in the assessment of the degree of septic severity and to aid in the risk stratification of critically ill septic patients. PATHFAST Presepsin improves the diagnosis and prognosis of sepsis defining its level of severity. It is a valid indicator of risk stratification in septic patients. Due to the fast analysis within 15 minutes and the high prognostic value even at patient’s admission, PATHFAST Presepsin is useful in laboratories, emergency and intensive care units and neonatal departments.
To find out more visit: Emergency and Sepsis Markers – AB Scientific